IRCT20100119003106N38招募中2 期
Comparison of the Efficacy and Safety of Simvastatin 2% Topical Gel with Placebo in Treatment of Acne Vulgaris Patients
Islamic Azad University, Pharmaceutical Sciences Branch0 个研究点目标入组 30 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit(—)
- 性别
- All
入选标准
- •Patients with mild and moderate acne vulgaris
排除标准
- •Pregnant women
- •Breastfeeding women
- •The patients with dermatological malignancy
- •The patients with burning
- •The patients with infection
- •The patients which have known hypersensitivity to simvastatin
- •The patients which have received any topical or oral medications for acne vulgaris in the last one month
研究者
相似试验
招募中
不适用
Effect of Simvastatin in Treatment of Uterine LeiomyomaIRCT20080831001141N34Royan Institute60
已完成
不适用
Comparing the bone regeneration capacity along with different clinical criteria of xenograft and simvastatiCTRI/2022/10/046426Punjab Government Dental College and Hospital Amritsar22
已完成
不适用
Evaluation of the efficacy of simvastatin use in Systemic Sclerosis patients: A Randomized Clinical TrialSystemic SclerosisRBR-36qz3pSociedade Brasileira de Reumatologia
进行中(未招募)
不适用
Safety and efficacy of the addition of simvastatin to panitumumab in k-ras mutant advanced or metastatic colorectal cancer patients.A single-arm, multicenter, phase II study using a Simon two stage design. - RASTAT-PEUCTR2009-014452-30-NLAcademisch ziekenhuis Leiden acting under the name of Leids Universitair Medisch Centrum
进行中(未招募)
不适用
Safety and efficacy of the addition of simvastatin to cetuximab in k-ras mutant advanced or metastatic colorectal cancer patients.A single-arm, multicenter, phase II study using a Simon two stage design. - RASTAT-Ck-ras mutant advanced or metastatic colorectal cancer failing prior 5-FU, oxaliplatin, and irinotecan containing regimens.MedDRA version: 12.1Level: LLTClassification code 10061451Term: Colorectal cancerEUCTR2009-017384-42-NLAcademisch ziekenhuis Leiden acting under the name of Leids Universitair Medisch Centrum
